These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9988460

  • 1. Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma.
    Dahlén SE.
    Clin Exp Allergy; 1998 Nov; 28 Suppl 5():141-6; discussion 171-3. PubMed ID: 9988460
    [Abstract] [Full Text] [Related]

  • 2. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM, Kopeć A.
    Pneumonol Alergol Pol; 2010 Nov; 78(1):68-73. PubMed ID: 20162521
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.
    Smith LJ.
    BioDrugs; 2001 Nov; 15(4):239-49. PubMed ID: 11437689
    [Abstract] [Full Text] [Related]

  • 4. Use of leukotriene antagonists in childhood asthma.
    Krawiec ME, Wenzel SE.
    Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
    [Abstract] [Full Text] [Related]

  • 5. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
    Claesson HE, Dahlén SE.
    J Intern Med; 1999 Mar; 245(3):205-27. PubMed ID: 10205583
    [Abstract] [Full Text] [Related]

  • 6. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z, Sterk PJ.
    Ned Tijdschr Geneeskd; 1998 Jan 10; 142(5):72-8. PubMed ID: 12013053
    [Abstract] [Full Text] [Related]

  • 7. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P, Baccard N, Advenier C.
    Pharmacol Res; 1999 Jul 10; 40(1):15-29. PubMed ID: 10378986
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Henriksen AH, Bjermer L.
    Tidsskr Nor Laegeforen; 1997 Feb 20; 117(5):647-51. PubMed ID: 9102953
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [May the Force be with antileukotriene drugs].
    Szczeklik A.
    Pneumonol Alergol Pol; 2010 Feb 20; 78(1):1-2. PubMed ID: 20162512
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H.
    Allergy; 2001 Feb 20; 56 Suppl 66():7-11. PubMed ID: 11421935
    [Abstract] [Full Text] [Related]

  • 16. The prospects for long-term intervention in asthma with antileukotrienes.
    Smith LJ.
    Clin Exp Allergy; 1998 Nov 20; 28 Suppl 5():154-63; discussion 171-3. PubMed ID: 9988462
    [Abstract] [Full Text] [Related]

  • 17. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H.
    Pediatrics; 2001 Feb 20; 107(2):381-90. PubMed ID: 11158473
    [Abstract] [Full Text] [Related]

  • 18. Critical appraisal of antileukotriene use in asthma management.
    Polosa R.
    Curr Opin Pulm Med; 2007 Jan 20; 13(1):24-30. PubMed ID: 17133121
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.